Skip to main content

Drugs, Alcohol, and Pregnant Women: Anesthetic Implications for Mother and Newborn

  • Chapter
  • First Online:
  • 1007 Accesses

Abstract

The prevalence of substance abuse among young adults has increased markedly over the last 20 years. Since nearly 90% of drug-abusing women are of childbearing age, it is likely that the clinician will encounter pregnant women who abuse illicit drugs [1]. As many case reports confirm, life-threatening complications may result when the physiologic changes of pregnancy are combined with the adverse effects of drug abuse [2]. Anesthesiologists are likely to meet the drug-abusing parturient first in an acute setting either when labor analgesia is requested or in an emergency situation such as fetal distress, placental abruption, uterine rupture, or sudden onset of life-threatening maternal dysrhythmias. Risk factors suggesting drug abuse in pregnancy include lack of prenatal care, history of premature labor, and cigarette smoking [3]. The most common illicit substances encountered are alcohol, cocaine, amphetamines, opioids, marijuana, and tobacco.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. National Survey on Drug Use and Health. Substance abuse during pregnancy: 2002 and 2003 update. www.oas.samhsa.gov/2k5/pregnancy/pregnancy.htm. Accessed 13 Sep 2010.

  2. Samuels SI, Maze A, Albright G. Cardiac arrest during cesarean section in a chronic amphetamine abuser. Anesth Analg. 1979;58:528–30.

    Article  PubMed  CAS  Google Scholar 

  3. Floyd RL, Decoufle P, Hungerford DW. Alcohol use prior to pregnancy recognition. Am J Prev Med. 1999;17:101–7.

    Article  PubMed  CAS  Google Scholar 

  4. State vs. Regina McKnight. 2003.

    Google Scholar 

  5. Commonwealth of Kentucky vs. Ina Cochran. case#2008-sc-000095. 2005.

    Google Scholar 

  6. American College of Obstetricians and Gynecologists. Committee opinion on obstetrics: Maternal and fetal medicine. Cocaine in pregnancy ACOG committee opinion No:114, Washington, DC. September 1992.

    Google Scholar 

  7. Kilmer G, Roberts H, Hughes E, Li Y, Valluru B, Fan A, et al. Surveillance of certain health behaviors and conditions among states and selected local areas – behavioral risk factor surveillance system, United States, 2006. MMWR Surveill Summ. 2008;57(7):1–188.

    PubMed  Google Scholar 

  8. Kuczkowski KM. Anesthetic implications of drug abuse in pregnancy. J Clin Anesth. 2003;15:382–94.

    Article  PubMed  Google Scholar 

  9. Cohen-Kerem R, Koren G. Antioxidants and fetal protection against ethanol teratogenicity I. review of the experimental data and implications to humans. Neurotoxicol Teratol. 2003;25:1–9.

    Article  PubMed  CAS  Google Scholar 

  10. Ornoy A, Ergaz Z. Alcohol abuse in pregnant women: effects on the fetus and newborn, mode of action and maternal treatment. Int J Environ Res Public Health. 2010;7:364–79.

    Article  PubMed  Google Scholar 

  11. Keegan J, Parva M, Finnegan M, Gerson A, Belden M. Addiction in pregnancy. J Addict Dis. 2010;29:175–91.

    Article  PubMed  Google Scholar 

  12. Lemoine P, Harousseau H, Borteryu JP, Menuet JC. Children of alcoholic parents: abnormalities observed in 127 cases. Ouest Med. 1968;8:476–82.

    Google Scholar 

  13. Jones KL, Smith DW. Recognition of the fetal alcohol syndrome in early infancy. Lancet. 1973;2:999–1001.

    Article  Google Scholar 

  14. Hannigan JH, Armant DR. Alcohol in pregnancy and neonatal outcome. Semin Neonatol. 2000;5:243–54.

    Article  PubMed  CAS  Google Scholar 

  15. Floyd RL, Jack BW, Cefalo R, Atrash H, Mahoney J, Herron A. The clinical content of preconception care: alcohol, tobacco, and illicit drug exposures. Am J Obstet Gynecol. 2008;199:s333–8.

    Article  PubMed  Google Scholar 

  16. Kesmodel U, Wisborg K, Olsen SF, Henriksen TB, Secher NJ. Moderate alcohol intake in pregnancy and the risk of spontaneous abortion. Alcohol Alcohol. 2002;37:87–92.

    PubMed  Google Scholar 

  17. Martinez-Frias ML, Bernejo E, Rodriguez-Pinilla E, Frias JL. Risk for congenital anomalies associated with different sporadic and daily doses of alcohol consumption during pregnancy: a case control study. Birth Defects Res A Clin Mol Teratol. 2004;70:194–200.

    Article  PubMed  CAS  Google Scholar 

  18. Stoler JM, Holmes LB. Recognition of facial features of fetal alcohol syndrome in the newborn. Am J Med Genet. 2004;127C:21–4.

    Article  PubMed  Google Scholar 

  19. May PA, Gossage JP. Estimating the prevalence of fetal alcohol syndrome. A summary. Alcohol Res Health. 2005;25:159–67.

    Google Scholar 

  20. Hoyme HE, May PA, Kalberg WO, Kodituwakku P, Gosssage JP, Trujillo PM, et al. A practical clinical approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 Institute of Medicine criteria. Pediatrics. 2005;115:39–47.

    Article  PubMed  Google Scholar 

  21. Banakar MK, Kudlur NS, George S. Fetal alcohol spectrum disorder (FASD). Indian J Pediatr. 2009;76:1173–5.

    Article  PubMed  Google Scholar 

  22. Wagner CL, Katikaneni LD, Cox TH, et al. The impact of prenatal drug exposure on the neonate. Obstet Gynecol Clin North Am. 1998;25:169–94.

    Article  PubMed  CAS  Google Scholar 

  23. Han YH. Why do chronic alcoholics require more anesthesia? Anesthesiology. 1969;30:2.

    Article  Google Scholar 

  24. Swerdlow BN, Holley FO, Maitre PO, et al. Chronic alcohol intake does not change thiopental anesthetic requirement, pharmacokinetics, or pharmacodynamics. Anesthesiology. 1990;72:455–61.

    Article  PubMed  CAS  Google Scholar 

  25. Chestnut DH, Polley LS, Tsen LC, Wong CA. Obstetric anesthesia principles and practice. 4th ed. Philadelphia, PA: Mosby Elsevier; 2009. p. 1134–7.

    Google Scholar 

  26. Russell M, Martier S, Sokol R, Mudar P, Jacobson S, Jacobson J. Detecting risk drinking during pregnancy: a comparison of four screening questionnaires. Am J Public Health. 1996;86:1435–9.

    Article  PubMed  CAS  Google Scholar 

  27. Burns E, Gray R, Smith LA. Brief screening questionnaires to identify problem drinking during pregnancy: a systematic review. Addiction. 2010;105:601–14.

    Article  PubMed  Google Scholar 

  28. Gareri J, Klein J, Koren G. Drug of abuse testing in meconium. Clin Chim Acta. 2006;366:101–11.

    Article  PubMed  CAS  Google Scholar 

  29. Ostrea Jr EM, Hernandez JD, Bielawski DM, Kan JM, et al. Fatty acid ethyl esters in meconium: are they biomarkers of fetal alcohol exposure and effect? Alcohol Clin Exp Res. 2006;30(7):1152–9.

    Article  PubMed  CAS  Google Scholar 

  30. Burd L, Hofer R. Biomarkers for detection of prenatal alcohol exposure: a critical review of fatty acid ethyl esters in meconium. Birth Defects Res A Clin Mol Teratol. 2008;82(7):487–93.

    Article  PubMed  CAS  Google Scholar 

  31. National Institute on Drug Abuse SAaMHSA: Results from the 2008 National Survey on Drug Use and Health: National Findings. Rockville, MD: National Institute on Drug Abuse; 2009.

    Google Scholar 

  32. King JC. Substance abuse in pregnancy. Postgrad Med J. 1997;102:135–50.

    CAS  Google Scholar 

  33. McCalla S, Minkoff HL, Feldman J, et al. Predictors of cocaine use in pregnancy. Obstet Gynecol. 1992;79:641–4.

    PubMed  CAS  Google Scholar 

  34. Birnbach DJ, Browne IM, Kim A, et al. Identification of polysubstace abuse in the parturient. Br J Anaesth. 2001;87:488–90.

    Article  PubMed  CAS  Google Scholar 

  35. Oyler J, Darwin WD, Preston KL, et al. Cocaine disposition in the meconium from newborns of cocaine abusing mothers and urine of adult drug users. J Anal Toxicol. 1996;20(6):453–562.

    PubMed  CAS  Google Scholar 

  36. Plessinger MA, Woods JR. Maternal, placental and fetal pathophysiology of cocaine exposure during pregnancy. Clin Obstet Gynecol. 1993;36:267–78.

    Article  PubMed  CAS  Google Scholar 

  37. Andres RL. Social and illicit drug use in pregnancy. Maternal fetal med: principles and practice. 5th ed. W.B. Saunders: Philadelphia, PA; 2004. p. 55–67.

    Google Scholar 

  38. Buehler BA. Cocaine how dangerous is it during pregnancy? Nebr Med J. 1995;80:116–7.

    PubMed  CAS  Google Scholar 

  39. Moen MD, Caliendo MJ, Marshall W, et al. Hepatic rupture in pregnancy associated with cocaine use. Obstet Gynecol. 1993;82:687–9.

    Article  PubMed  CAS  Google Scholar 

  40. Chao CR. Cardiovascular effects of cocaine during pregnancy. Semin Perinatol. 1996;20:107–14.

    Article  PubMed  CAS  Google Scholar 

  41. Moore TR, Sorg J, Miller L, et al. Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus. Am J Obstet Gynecol. 1986;155:883–8.

    PubMed  CAS  Google Scholar 

  42. Schindler CW, Tella SR, Erzanki HK. Pharmacological mechanisms of cocaine’s cardiovascular effects. Drug Alcohol Depend. 1995;37:183–91.

    Article  PubMed  CAS  Google Scholar 

  43. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med. 2001;345:351–8.

    Article  PubMed  CAS  Google Scholar 

  44. Shanti CM, Lucas CE. Cocaine and the critical care challenge. Crit Care Med. 2003;31:1851–9.

    Article  PubMed  Google Scholar 

  45. Restrepo CS, Carrillo JA, Martínez S, Ojeda P, Rivera AL, Hatta A. pulmonary complications from cocaine and cocaine based substances: imaging maifestations. Radiographics. 2007;27(4):941–56.

    Article  PubMed  Google Scholar 

  46. Kuczkowski KM, Birnbach DJ, van Zundert A. Drug Abuse in the Parturient. Semin Anesth Periop Med Pain. 2000;19:216–24.

    Article  Google Scholar 

  47. Kreek MJ. Cocaine, dopamine and the endogenous opioid system. J Addict Dis. 1996;15:73–96.

    Article  PubMed  CAS  Google Scholar 

  48. Vertommen JD, Hughes SC, Rosen MA, et al. Hydralazine, does not restore uterine blood flow during cocaine-induced hypertension in the pregnant ewe. Anesthesiology. 1992;76:580–7.

    Article  PubMed  CAS  Google Scholar 

  49. Guidelines 2010 for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010;122:S829–61.© 2010 American Heart Association, Inc.

    Google Scholar 

  50. Lange RA, Cigarroa RG, Flores ED, McBride W, Kim AS, Wells PJ, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med. 1990;112:897–903.

    PubMed  CAS  Google Scholar 

  51. Kain ZN, Mayes LC, Ferris CA, et al. Cocaine-abusing parturients undergoing cesarean section: a cohort study. Anesthesiology. 1996;85:1028–35.

    Article  PubMed  CAS  Google Scholar 

  52. Spence MR, Williams R, DiGregorio GJ, et al. The relationship between recent cocaine use and pregnancy outcome. Obstet Gynecol. 1991;78:326–9.

    PubMed  CAS  Google Scholar 

  53. Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009;104:1085–99.

    Article  PubMed  Google Scholar 

  54. Good MM, Solt I, Acuna JG, Rotsmensch S, Kim MJ. Methamphetamine use during pregnancy. Obstet Gynecol. 2010;116(2):330–4.

    Article  PubMed  Google Scholar 

  55. Terplan M, Smith EJ, Kozloski MJ, Pollack HA. Methamphetamine use among pregnant women. Obstet Gynecol. 2009;113:1285–91.

    PubMed  Google Scholar 

  56. Arria AM, Derauf C, Lagasse LL, Grant P, Shah R, Smith L, et al. Methamphetamine and other substance use during pregnancy. preliminary estimates from the infant development, environment, and lifestyle (IDEAL) study. Matern Child Health J. 2006;10:293–302.

    Article  PubMed  Google Scholar 

  57. Gonzales R, Mooney L, Rawson AR. The methamphetamine problem in the united states. Annu Rev Public Health. 2010;31:385–98.

    Article  PubMed  Google Scholar 

  58. Inoue H, Nakatome M, Terada M, Mizuno M, Ono R, Iino M, et al. Maternal methamphetamine administration during pregnancy influences on fetal rat heart development. Life Sci. 2004;74:1529–40.

    Article  PubMed  CAS  Google Scholar 

  59. Bateman DN, McElhatton PR, Dickinson D, Wren C, Matthews JN, O’Keffe M, et al. A case control study to examine the pharmacological factors underlying ventricular septal defects in the north of England. Eur J Clin Pharmacol. 2004;60:635–41.

    Article  PubMed  CAS  Google Scholar 

  60. Werler MM, Sheehan JE, Mitchell AA. Association of vasoconstrictive exposures with risks of gastroschisis and small intestinal atresia. Epidemiology. 2003;14:349–54.

    PubMed  Google Scholar 

  61. Thomas DB. Cleft palate, mortality and morbidity of infants of substance abusing mothers. J Paediatr Child Health. 1995;31:457–60.

    Article  PubMed  CAS  Google Scholar 

  62. Bays J. Fetal vascular disruption with prenatal exposure to cocaine or methamphetamine. Pediatrics. 1991;87:416–8.

    PubMed  CAS  Google Scholar 

  63. Nora JJ, Vargo TA, Nora AH, Love KE, McNamara DG. Dexamphetamine: a possible environmental trigger in cardiovascular malformations. Lancet. 1970;1:1290–1.

    Article  PubMed  CAS  Google Scholar 

  64. Little BB, Snell LM, Gilstrap 3rd LC. Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol. 1988;72:541–4.

    PubMed  CAS  Google Scholar 

  65. Milkovich L, Van der Berg BJ. effects of antenatal exposure to anorectic drugs. Am J Obstet Gynecol. 1977;129:637–42.

    PubMed  CAS  Google Scholar 

  66. Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr. 1987;111:571–8.

    Article  PubMed  CAS  Google Scholar 

  67. Stewart JL, Meeker JE. Fetal and infant deaths associated with maternal methamphetamine abuse. J Anal Toxicol. 1997;21:515–7.

    PubMed  CAS  Google Scholar 

  68. Michel R, Adams AP. Acute amphetamine abuse. Problems during general anesthesia for neurosurgery. Anaesthesia. 1979;34:1016–9.

    Article  PubMed  CAS  Google Scholar 

  69. Johnston RR, Way WL, Miller RD. Alteration of anesthetic requirement by amphetamine. Anesthesiology. 1972;36:357–63.

    Article  PubMed  CAS  Google Scholar 

  70. Floyd RL, Jack BW, Cefalo R, Atrash H, Mahoney J, Herron A, et al. The clinical content of preconception care: alcohol, tobacco, and illicit drug exposures. Am J Obstet Gynecol. 2008;199:s333–9.

    Article  PubMed  Google Scholar 

  71. Brown HL, Britton KA, Mahaffey D, Brizendine E, Hiert AK, Turnquest MA. Methadone maintenance in pregnancy: a reappraisal. Am J Obstet Gynecol. 1998;179:459–63.

    Article  PubMed  CAS  Google Scholar 

  72. Minozzi S, Amato L, Vecchi S, Davoli M. Maintenance agonist treatments for opiate dependent pregnant women. Cochrane database Syst Rev. 2008;CD006318.

    Google Scholar 

  73. Creasy RK, Resnik R, Iams JD. Creasy and Resnik’s maternal-fetal medicine: principles and practice. Philadelphia, PA: Saunders/Elsevier; 2009.

    Google Scholar 

  74. Lim S, Prasad MR, Samuels P, Gardner DK, Cordero L. High dose methadone in pregnant women and it’s effect on duration of neonatal abstinence syndrome. Am J Obstet Gynecol. 2009;200:70el–5.

    Article  Google Scholar 

  75. Rettig R. Federal regulation of methadone: table of contents and executive summary. Washington, DC: National Academy Press; 1995.

    Google Scholar 

  76. Rayburn W, Bogenschutz MP. Pharmacotherapy for pregnant women with addiction. Am J Obstet Gynecol. 2004;191:1885–97.

    Article  PubMed  CAS  Google Scholar 

  77. Briggs G, Freeman R, Yaffe J. Drugs in pregnancy and lactation. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.

    Google Scholar 

  78. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy: effects and management. Obstet Gynecol Clin N Am. 1998;25:139–51.

    Article  CAS  Google Scholar 

  79. Fajemirokun-Odudeyi O, Sinha C, Tutty S, Pairaudeau P, Armstrong D, Phillips T, et al. Pregnancy outcomes in women who use opiates. Eur J Obstet Gynecol Reprod Biol. 2006;126(2):170–5.

    Article  PubMed  CAS  Google Scholar 

  80. Ludlow JP, Evans SF, Hulse G. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse. Aust N Z J Obstet Gynaecol. 2004;44(4):301–6.

    Article  Google Scholar 

  81. Gold MS, Pottash AL, Sweeney DR, Kleber HD. Opiate withdrawal using clonidine. A safe, effective, and rapid nonopiate treatment. JAMA. 1980;243:343–6.

    Article  PubMed  CAS  Google Scholar 

  82. Kuczkowski KM, Birnbach DDJ. The HIV infected parturient: is neuraxial anesthesia contraindicated? Curr Anesthesiol Rep. 2000;2:118–21.

    Google Scholar 

  83. Ashton CH. Biomedical benefits of cannnabinoids. Addict Biol. 1999;4:111–26.

    Article  PubMed  CAS  Google Scholar 

  84. Shiono PH, Klebanoff MA, Nugent RP, Cotch MF, Wilkins DG, Rollins DE, et al. The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study. Am J Obstet Gynecol. 1995;172:19–27.

    Article  PubMed  CAS  Google Scholar 

  85. Van Gelder M, Reefhuis J, Caton A, Werler M, Druschel C, et al. Characteristics of pregnant illicit drug users and associations between cannabis use an perinatal outcome in a population based study. Drug Alcohol Depend. 2010;109:243–7.

    Article  PubMed  Google Scholar 

  86. Musty RE, Reggio P, Consroe P. A review of recent advances in cannaboid research and the 1994 international symposium on cannabis and the cnnaboids. Life Sci. 1995;56:1933–40.

    Article  PubMed  CAS  Google Scholar 

  87. National institute on drug abuse (NIDA) research report series: Marijuana abuse. July 2005. NIH publication number 05–3859.

    Google Scholar 

  88. Smith CG, Asch RH. Drug abuse and reproduction. Fertil Steril. 1987;48:355–73.

    PubMed  CAS  Google Scholar 

  89. Mallat A, Roberson J, Broch-Utne JG. Preoperative marijuana inhalation – an airway concern. Can J Anaesth. 1996;43:691–3.

    Article  PubMed  CAS  Google Scholar 

  90. IARC (International agency for research on cancer) working group on the evaluation of carcinogenic risks to humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum. 2004;83:1–1438.

    Google Scholar 

  91. Goodwin RD, Keyes K, Simuro N. Mental disorders and nicotine dependence among pregnant women in the united states. Obstet Gynecol. 2007;109:875–83.

    Article  PubMed  Google Scholar 

  92. Kandel DB, Griesler PC, Schaffran C. Educational attainment and smoking among women: risk factors and consequences for offspring. Drug Alcohol Depend. 2009;104 Suppl 1:S24–33.

    Article  PubMed  Google Scholar 

  93. Thielen A, Klus H, Muller L. Tobacco smoke: unraveling a controversial subject. Exp Toxicol Pathol. 2008;60:141–56.

    Article  PubMed  CAS  Google Scholar 

  94. Andres RL, Day MC. Perinatal complications associated with maternal tobacco use. Semin Neonatol. 2000;5:231–41.

    Article  PubMed  CAS  Google Scholar 

  95. Einarson A, Riordan S. Smoking in pregnancy and lactation: a review of risks and cessation strategies. Eur J Clin Pharmacol. 2009;65:325–30.

    Article  PubMed  Google Scholar 

  96. MacDorman MF, Cnattingius S, Hoffman HJ, Kramer MS, Haglund B. Sudden infant death syndrome and smoking in the United states and Sweden. Am J Epidemiol. 1997;146:249–57.

    Article  PubMed  Google Scholar 

  97. Simmons LE, Rubens CE, Darmstadt GL, et al. Preventing preterm birth and neonatal mortality: exploring the epidemiology, causes and interventions. Semon Perinatol. 2010;34(6):408–15.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Migdalia Saloum MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Saloum, M., Epstein, J.N. (2012). Drugs, Alcohol, and Pregnant Women: Anesthetic Implications for Mother and Newborn. In: Bryson, E., Frost, E. (eds) Perioperative Addiction. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0170-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-0170-4_11

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-0169-8

  • Online ISBN: 978-1-4614-0170-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics